FDA may modernize trial oversight

Share this article:
The FDA has a stale and outdated regulatory system for overseeing clinical trial compliance, but several initiatives are under way to modernize it, according to Division of Scientific Investigations director Leslie Ball. Speaking at the Food and Drug Law Institute's annual meeting, Ball said the agency has high hopes for updating its clinical trial regulatory scheme under a “transformation initiative” in partnership with Duke University Medical Center.

Under the agreement, Duke will host a public-private partnership with broad representation from government, industry, patient advocacy groups, professional societies, and academia to develop new standards and identify new methods and technologies that improve safety, increase the quality of information derived from clinical trials, and make the research process more efficient.

Among ideas to be explored are: establishing national standards for a wide range of research functions to streamline current approaches to starting and conducting clinical trials; exploring alternative models for institutional review boards to minimize duplication of effort in multi-site clinical trials and identifying strategies to enhance the process of obtaining informed consent from trial participants; establishing accreditation programs for both clinical investigators and research sites; and extending technology use to improve data management. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.